LSTA FY 2008 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83,541-63.9% YoY

Gross Profit

$51,56261.7% margin

Operating Income

-$9M-11052.6% margin

Net Income

-$9M-11062.9% margin

EPS (Diluted)

$-2295.00

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$2M

Total Liabilities

$961,140

Stockholders' Equity

$863,176

Cash & Equivalents

$430,786

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83,541	$231,664	-63.9%
Gross Profit	$51,562	$206,817	-75.1%
Operating Income	-$9M	-$10M	+11.5%
Net Income	-$9M	-$10M	+11.5%